Clinical Trial Update: Selinexor With Combination With Induction/Consolidation Therapy in Acute Myeloid Leukemia Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating selinexor in combination with induction/consolidation therapy for untreated adult acute myeloid leukemia; the study is currently acti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Selinexor (selinexor)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Untreated Adult Acute Myeloid Leukemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING